首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD- UMOD and ADTKD- MUC1
【24h】

Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD- UMOD and ADTKD- MUC1

机译:常染色体占优势微管间肾病:ADTKD-UMOD和ADTKD-MUC1患者的临床介绍

获取原文
获取原文并翻译 | 示例
           

摘要

Rationale & ObjectiveAutosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare underdiagnosed cause of end-stage renal disease (ESRD). ADTKD is caused by mutations in at least 4 different genes:MUC1,UMOD,HNF1B, andREN. Study DesignRetrospective cohort study. Setting & Participants56 families (131 affected individuals) with ADTKD referred from different Spanish hospitals. Clinical, laboratory, radiologic, and pathologic data were collected, and genetic testing forUMOD,MUC1,REN, andHNF1Bwas performed. PredictorsHyperuricemia, ultrasound findings, renal histology, genetic mutations. OutcomesAge at ESRD, rate of decline in estimated glomerular filtration rate. ResultsADTKD was diagnosed in 25 families (45%), 9 carriedUMODpathogenic variants (41 affected members), and 16 carried theMUC1pathogenic mutation c.(428)dupC (90 affected members). No pathogenic variants were identified inRENorHNF1B. Among the 77 individuals who developed ESRD, median age at onset of ESRD was 51 years for those with ADTKD-MUC1versus 56 years (P=0.1) for those with ADTKD-UMOD. Individuals with theMUC1duplication presented higher risk for developing ESRD (HR, 2.24;P=0.03). The slope of decline in estimated glomerular filtration rate showed no significant difference between groups (?3.0mL/min/1.73m2per year in the ADTKD-UMODgroup versus??3.9mL/min/1.73m2per year in the ADTKD-MUC1group;P=0.2). The prevalence of hyperuricemia was significantly higher in individuals with ADTKD-UMOD(87% vs 54%;P=0.006). Although gout occurred more frequently in this group, the difference was not statistically significant (24% vs 7%;P=0.07). LimitationsRelatively small Spanish cohort.MUC1analysis limited to cytosine duplication. ConclusionsThe main genetic cause of ADTKD in our Spanish cohort is theMUC1pathogenic mutation c.(428)dupC. Renal survival may be worse in individuals with theMUC1mutation than in those withUMODmutations. Clinical presentation does not permit distinguishing between these variants. However, hyperuricemia and gout are more frequent in individuals with ADTKD-UMOD.
机译:理由和客观透明透明度显性微管膨胀性肾病(ADTKD)是一种罕见的末期肾病发病原因(ESRD)。 Adtkd是由至少4个不同基因的突变引起的:muc1,umod,hnf1b,andren。研究DesignRetrospietive Cohort研究。设定与参与者56个家庭(131个受影响的个人),adtkd来自不同的西班牙医院。收集了临床,实验室,放射学和病理数据,并进行了遗传检测突发,MUC1,REN,ANDHNF1BWA。预测性高血肿,超声检查,肾组织学,基因突变。 ESRD的Outcomesage,估计肾小球过滤速率下降率。结果adtkd被诊断为25个家族(45%),9个携带的Puld病变(41个受影响的成员)和16个携带的Themuc1pathogenic突变c。(428)Dupc(90名受影响的成员)。没有鉴定致病变体inrenorhnf1b。在开发ESRD的77个个人中,ESRD发作的中位年龄为56岁的年龄为56岁(P = 0.1),适用于ADTKD-UMOD的人。具有Themuc1的个体呈现出更高的开发ESRD的风险(HR,2.24; P = 0.03)。估计的肾小球过滤速率下降的斜率显示,组之间没有显着差异(adtkd-umodgroup与adtkd-muodgroup的3.0ml / min / 1.73m2,在adtkd-muc1group中的3.9ml / min / 1.73m2; p = 0.2 )。患有Adtkd-Umod的个体的高尿酸血症的患病率显着高(87%Vs 54%; P = 0.006)。虽然在该组中更频繁地发生痛风,但差异没有统计学意义(24%vs 7%; P = 0.07)。限制性小西班牙Cohort.muc1分析限于胞嘧啶复制。结论我们西班牙队列中Adtkd的主要遗传原因是Themuc1Pathogenic突变C.(428)Dupc。肾脏生存可能比在与那些有关的人中的个人中更糟糕。临床介绍不允许区分这些变体。然而,在具有Adtkd-Umod的个体中,高尿酸血症和痛风更频繁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号